- Home
- EPM vs IKT Comparison
EPM vs IKT Comparison
Compare EPM & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPM
- IKT
- Stock Information
- Founded
- EPM 2003
- IKT 2008
- Country
- EPM United States
- IKT United States
- Employees
- EPM N/A
- IKT N/A
- Industry
- EPM Oil & Gas Production
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- EPM Energy
- IKT Health Care
- Exchange
- EPM Nasdaq
- IKT Nasdaq
- Market Cap
- EPM 174.3M
- IKT 140.5M
- IPO Year
- EPM 1996
- IKT 2020
- Fundamental
- Price
- EPM $5.18
- IKT $1.68
- Analyst Decision
- EPM Hold
- IKT Buy
- Analyst Count
- EPM 1
- IKT 2
- Target Price
- EPM $4.50
- IKT $8.00
- AVG Volume (30 Days)
- EPM 147.4K
- IKT 104.1K
- Earning Date
- EPM 09-16-2025
- IKT 08-14-2025
- Dividend Yield
- EPM 9.47%
- IKT N/A
- EPS Growth
- EPM N/A
- IKT N/A
- EPS
- EPM N/A
- IKT N/A
- Revenue
- EPM $85,959,000.00
- IKT N/A
- Revenue This Year
- EPM $0.85
- IKT N/A
- Revenue Next Year
- EPM $0.56
- IKT N/A
- P/E Ratio
- EPM N/A
- IKT N/A
- Revenue Growth
- EPM 3.79
- IKT N/A
- 52 Week Low
- EPM $4.05
- IKT $1.12
- 52 Week High
- EPM $6.14
- IKT $4.20
- Technical
- Relative Strength Index (RSI)
- EPM 58.96
- IKT 45.73
- Support Level
- EPM $4.96
- IKT $1.66
- Resistance Level
- EPM $5.23
- IKT $1.87
- Average True Range (ATR)
- EPM 0.11
- IKT 0.10
- MACD
- EPM 0.00
- IKT -0.01
- Stochastic Oscillator
- EPM 87.21
- IKT 33.82
About EPM Evolution Petroleum Corporation Inc.
Evolution Petroleum Corp is an independent oil and gas company operating in the United States. It is engaged predominantly in the acquisition, exploitation, and development of properties for the production of crude oil and natural gas, onshore in the United States. The company's revenues are generated from its crude oil, natural gas, and NGL production from the Jonah Field in Sublette County, Wyoming; the Williston Basin in North Dakota; the Barnett Shale located in North Texas; the Hamilton Dome Field in Wyoming; and the Delhi Field in Northeast Louisiana.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.